267 related articles for article (PubMed ID: 27327768)
1. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
2. Agitation-Induced Aggregation of Lysine- And Interchain Cysteine-Linked Antibody-Drug Conjugates.
Johann F; Wöll S; Winzer M; Gieseler H
J Pharm Sci; 2024 May; 113(5):1265-1274. PubMed ID: 38070776
[TBL] [Abstract][Full Text] [Related]
3. Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs).
Yao H; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848651
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells.
Poźniak M; Porębska N; Krzyścik MA; Sokołowska-Wędzina A; Jastrzębski K; Sochacka M; Szymczyk J; Zakrzewska M; Otlewski J; Opaliński Ł
Mol Med; 2021 May; 27(1):46. PubMed ID: 33962559
[TBL] [Abstract][Full Text] [Related]
5. Linkers Having a Crucial Role in Antibody-Drug Conjugates.
Lu J; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329
[TBL] [Abstract][Full Text] [Related]
6. Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.
Wang YJ; Li YY; Liu XY; Lu XL; Cao X; Jiao BH
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28098746
[TBL] [Abstract][Full Text] [Related]
7. A Genetically Encoded Photocaged Cysteine for Facile Site-Specific Introduction of Conjugation-Ready Thiol Residues in Antibodies.
Osgood AO; Roy SJS; Koo D; Gu R; Chatterjee A
Bioconjug Chem; 2024 Apr; 35(4):457-464. PubMed ID: 38548654
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles as modifiers of antibody-drug conjugate efficacy.
Barok M; Puhka M; Yazdi N; Joensuu H
J Extracell Vesicles; 2021 Feb; 10(4):e12070. PubMed ID: 33613875
[TBL] [Abstract][Full Text] [Related]
9. Antibody Drug Conjugates: Nonclinical Safety Considerations.
Hinrichs MJ; Dixit R
AAPS J; 2015 Sep; 17(5):1055-64. PubMed ID: 26024656
[TBL] [Abstract][Full Text] [Related]
10. Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer.
Del Solar V; Contel M
J Inorg Biochem; 2019 Oct; 199():110780. PubMed ID: 31434020
[TBL] [Abstract][Full Text] [Related]
11. Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADC.
Figueroa I; Leipold D; Leong S; Zheng B; Triguero-Carrasco M; Fourie-O'Donohue A; Kozak KR; Xu K; Schutten M; Wang H; Polson AG; Kamath AV
MAbs; 2018 Jul; 10(5):738-750. PubMed ID: 29757698
[TBL] [Abstract][Full Text] [Related]
12. Automated online deconjugation of antibody-drug conjugate for small molecule drug profiling.
Thomas R; Song D; Pourmohamad T; Kurita K; Chin S; Dai L; Goyon A; Medley CD; Gruenhagen JA; Chen T
J Chromatogr A; 2024 Jan; 1715():464575. PubMed ID: 38150875
[TBL] [Abstract][Full Text] [Related]
13. Selective Reduction of Cysteine Mutant Antibodies for Site-Specific Antibody-Drug Conjugates.
Liao X; Haight A; Welch D; Han L
Bioconjug Chem; 2023 Dec; 34(12):2293-2301. PubMed ID: 37983167
[TBL] [Abstract][Full Text] [Related]
14. Fate of Antibody-Drug Conjugates in Cancer Cells.
Chalouni C; Doll S
J Exp Clin Cancer Res; 2018 Feb; 37(1):20. PubMed ID: 29409507
[TBL] [Abstract][Full Text] [Related]
15. Site-specific Antibody-Nitric Oxide Conjugate HN02 Possesses Improved Antineoplastic and Safety Properties.
Cheng T; Xie J; Yuan X; Guo M; Wu J; Wang M; Huang Z; Zhang J
J Immunother; 2024 Jun; 47(5):149-159. PubMed ID: 38557756
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Multi-attribute Analysis of Antibody-Drug Conjugates Enabled by Trapped Ion Mobility Spectrometry and Top-Down Mass Spectrometry.
Larson EJ; Roberts DS; Melby JA; Buck KM; Zhu Y; Zhou S; Han L; Zhang Q; Ge Y
Anal Chem; 2021 Jul; 93(29):10013-10021. PubMed ID: 34258999
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Sensitivity of Antibody-Drug Conjugate Efficacy to the Selection of Payload, Antibody, and Cell line.
Rao M; Murali S; Amores D; Yu F; Tsourkas A
Bioconjug Chem; 2024 Jan; 35(1):115-124. PubMed ID: 38173338
[TBL] [Abstract][Full Text] [Related]
18. Adnectin-drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors.
Lipovšek D; Carvajal I; Allentoff AJ; Barros A; Brailsford J; Cong Q; Cotter P; Gangwar S; Hollander C; Lafont V; Lau WL; Li W; Moreta M; O'Neil S; Pinckney J; Smith MJ; Su J; Terragni C; Wallace MA; Wang L; Wright M; Marsh HN; Bryson JW
Protein Eng Des Sel; 2018 May; 31(5):159-171. PubMed ID: 30247737
[TBL] [Abstract][Full Text] [Related]
19. Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.
Hamilton JZ; Pires TA; Mitchell JA; Cochran JH; Emmerton KK; Zaval M; Stone IJ; Anderson ME; Jin S; Waight AB; Lyon RP; Senter PD; Jeffrey SC; Burke PJ
ChemMedChem; 2021 Apr; 16(7):1077-1081. PubMed ID: 33369163
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives.
Zhang Y; Ding M; Wang L; Yin S; Zhang L; Cao X; Chen Z; Li W; Guo Q; Zhu S; Lu W; Yang T
PLoS One; 2023; 18(12):e0292871. PubMed ID: 38113206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
